Illuminating an Invisible Epidemic: A Systematic Review of the Clinical and Economic Benefits of Early Diagnosis and Treatment in Inflammatory Disease and Related Syndromes

A long-sought-after goal among healthcare professionals is to devise strategies that enhance patient care and simultaneously reduce expenses. Inflammatory diseases and chronic syndromes currently impose an immense social and economic burden with annual direct costs attributable to the reviewed group of inflammatory diseases and syndromes currently projected to be greater than $90B.

Similar Posts

Leave a Reply

Your email address will not be published.